The Use of Infliximab to Control Recurrent Cytokine Storms in EBV-Associated Angioimmunoblastic Lymphoma and Hemophagocytic Syndrome

Blood - United States
doi 10.1182/blood.v120.21.4887.4887
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology


Related search